SciELO - Scientific Electronic Library Online

 
vol.32 número2¿Qué podemos aprender de los errores en el abordaje de la crisis opioides en Estados Unidos?Manejo del tratamiento de úlcera corneal perforada secundaria a una infección fúngica índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

Links relacionados

  • En proceso de indezaciónCitado por Google
  • No hay articulos similaresSimilares en SciELO
  • En proceso de indezaciónSimilares en Google

Compartir


Revista de la OFIL

versión On-line ISSN 1699-714Xversión impresa ISSN 1131-9429

Resumen

SANCHEZ-SANZ, B; GARCIA-MUNOZ, C; ALONSO-PEREZ, L  y  FERRARI-PIQUERO, JM. Very early onset inflammatory bowel disease remission induced with oral gentamicin and vancomycin. Rev. OFIL·ILAPHAR [online]. 2022, vol.32, n.2, pp.203-205.  Epub 13-Feb-2023. ISSN 1699-714X.  https://dx.doi.org/10.4321/s1699-714x2022000200014.

Very early onset inflammatory bowel disease occurs in children under 6 years age. It is frequently associated to a diverse ethiology, dysbiosis being usually described as a triggering factor. Commonly, this population is highly resilient to inmmunosuppressant therapies.

We report here a medical case of a patient diagnosed with unclassified and steroid-dependent colitis, with a year of evolution, who had no responded to intensified therapy at home, and, therefore, was hospitalized at our centre. Treatment with oral antibiotics was intended as remission induction in combination with his usual inmmunomodulator treatment. Although clinical remission was observed at first stage, a new activity outbreak emerged requiring a second round of antibiotics therapy, which was unsuccessful and currently withdrawned.

Palabras clave : Inflammatory bowel disease; vancomycin; gentamicin.

        · resumen en Español     · texto en Español     · Español ( pdf )